These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1012 related articles for article (PubMed ID: 33952721)

  • 21. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
    Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
    BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma.
    Wang L; Zhang S; Li H; Xu Y; Wu Q; Shen J; Li T; Xu Y
    BMC Cancer; 2021 Jul; 21(1):876. PubMed ID: 34332578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A five-gene signature derived from m6A regulators to improve prognosis prediction of neuroblastoma.
    Wang Z; Cheng H; Xu H; Yu X; Sui D
    Cancer Biomark; 2020; 28(3):275-284. PubMed ID: 32176634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma Prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy Treatment Response.
    Jiang H; Ning G; Wang Y; Lv W
    Dis Markers; 2021; 2021():5576683. PubMed ID: 34221187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of RBM15 as a prognostic biomarker in prostate cancer involving the regulation of prognostic m6A-related lncRNAs.
    Hu B; Lin D; Liu Z; Chen R; Liu J; Wu Y; Wang T
    Eur J Med Res; 2024 Aug; 29(1):411. PubMed ID: 39118157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of prognostic metabolic genes in adrenocortical carcinoma and establishment of a prognostic nomogram: A bioinformatic study.
    Chen Q; Ren Z; Liu D; Jin Z; Wang X; Zhang R; Liu Q; Cheng W
    Medicine (Baltimore); 2021 Dec; 100(50):e27864. PubMed ID: 34918636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying subtypes and developing prognostic models based on N6-methyladenosine and immune microenvironment related genes in breast cancer.
    Wang L; Li J; Mei N; Chen H; Niu L; He J; Wang R
    Sci Rep; 2024 Jul; 14(1):16586. PubMed ID: 39020010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A seven-m6A regulator-related CpG site-based prognostic signature for endometrial carcinoma.
    Zhang X; Pang X; Huang Y; Qian S
    Medicine (Baltimore); 2021 Jul; 100(29):e26648. PubMed ID: 34398021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced expression of ferroportin1 and ceruloplasmin predicts poor prognosis in adrenocortical carcinoma.
    Zhu B; Zhi Q; Xie Q; Wu X; Gao Y; Chen X; Shi L
    J Trace Elem Med Biol; 2019 Dec; 56():52-59. PubMed ID: 31442954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma.
    Fang Q; Chen H
    Mol Med; 2020 Jun; 26(1):60. PubMed ID: 32552682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The m6A reader HNRNPC predicts adverse prognosis and promotes the progression of colorectal cancer.
    Yu YM; Hu Y
    Technol Health Care; 2024; 32(3):1445-1453. PubMed ID: 37661903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Prognostic Value of m6A RNA Methylation Regulators in Colon Adenocarcinoma.
    Liu T; Li C; Jin L; Li C; Wang L
    Med Sci Monit; 2019 Dec; 25():9435-9445. PubMed ID: 31823961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of immune-related biomarkers in adrenocortical carcinoma: Immune-related biomarkers for ACC.
    Peng Y; Song Y; Ding J; Li N; Zhang Z; Wang H
    Int Immunopharmacol; 2020 Nov; 88():106930. PubMed ID: 32919215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N6-methylandenosine-related lncRNAs play an important role in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma.
    Hu Y; Chen Y
    Sci Rep; 2021 Sep; 11(1):17844. PubMed ID: 34497315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of important invasion and proliferation related genes in adrenocortical carcinoma.
    Alshabi AM; Vastrad B; Shaikh IA; Vastrad C
    Med Oncol; 2019 Jul; 36(9):73. PubMed ID: 31321566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of an immune-related gene signature as a prognostic target and the immune microenvironment for adrenocortical carcinoma.
    Xu C; Qin C; Jian J; Peng Y; Wang X; Chen X; Wu D; Song Y
    Immun Inflamm Dis; 2022 Sep; 10(9):e680. PubMed ID: 36039643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioinformatic mining and validation of the effects of ferroptosis regulators on the prognosis and progression of pancreatic adenocarcinoma.
    Xu F; Zhang Z; Zhao Y; Zhou Y; Pei H; Bai L
    Gene; 2021 Aug; 795():145804. PubMed ID: 34175402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune signature of T follicular helper cells predicts clinical prognostic and therapeutic impact in lung squamous cell carcinoma.
    Xu F; Zhang H; Chen J; Lin L; Chen Y
    Int Immunopharmacol; 2020 Apr; 81():105932. PubMed ID: 31836430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer.
    Chen M; Nie ZY; Wen XH; Gao YH; Cao H; Zhang SF
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31808521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of survival-associated alternative splicing events and signatures in adrenocortical carcinoma based on TCGA SpliceSeq data.
    Xu N; Ke ZB; Lin XD; Lin F; Chen SH; Wu YP; Chen YH; Wei Y; Zheng QS
    Aging (Albany NY); 2020 Mar; 12(6):4996-5009. PubMed ID: 32217810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.